Vasopressin analogues.

Desmopressin acetate - endocrine

DDAVP/Desmopressin Intranasal Solution: intranasal solution. DDAVP Tablets: white scored tablets marked with strength. DDAVP/Desmopressin Injection: ampoules.

DDAVP/Desmopressin Intranasal Solution: Desmopressin acetate 100 micrograms/mL. DDAVP Tablets: Desmopressin acetate 0.1 mg , 0.2 mg . DDAVP/Desmopressin Injection: Desmopressin acetate 4 micrograms/mL.

DDAVP/Desmopressin Intranasal Solution: Diagnosis and treatment of vasopressin-sensitive cranial diabetes insipidus; establishing renal concentration capacity. DDAVP Tablets: Treatment of vasopressin-sensitive cranial diabetes insipidus; treatment of post-hypophysectomy polyuria/ polydipsia. DDAVP/Desmopressin Injection: Cranial diabetes insipidus.

DDAVP/Desmopressin Intranasal Solution: Diabetes insipidus treatment, 0.1 - 0.2 mL once or twice daily. Diabetes insipidus diagnosis, 0.2 mL as single dose. Limit fluid intake to maximum 0.5 litres from 1 hour before to 8 hours after administration.

Renal function testing, 0.4 mL. DDAVP Tablets: Diabetes insipidus, initially 0.1 mg three times daily. Maintenance 0.1 - 0.2 mg three times daily. Post-hypophysectomy polyuria/ polydipsia, titrate dose according to urine osmolality.

DDAVP/Desmopressin Injection: 1 - 4 micrograms intramuscularly, subcutaneously or intravenously

DDAVP/Desmopressin Intranasal Solution: Diabetes insipidus treatment, 0.05 - 0.2 mL daily, infants may require a lower dose. Diabetes insipidus diagnosis, 0.2 mL as single dose. Limit fluid intake to maximum 0.5 litres from 1 hour before to 8 hours after administration. Renal function testing, up to 1 year, 0.1 mL; 1 - 15 years, 0.2 mL. DDAVP Tablets: Diabetes insipidus, initially 0.1 mg three times daily. Maintenance 0.1 - 0.2 mg three times daily. Post-hypophysectomy polyuria/ polydipsia, titrate dose according to urine osmolality. DDAVP/Desmopressin Injection: Doses from 0.4 micrograms (0.1mL) may be used.

Cardiac insufficiency, hypertension.

Exclude psychogenic polydipsia and alcohol abuse before initiating therapy. Renal impairment, cardiovascular disease, electrolyte imbalance, cystic fibrosis. Pregnancy. Avoid fluid overload.

Indometacin (indomethacin), tricyclic antidepressants, chlorpromazine, carbamazepine.

Headache, stomach pain, nausea. Hyponatraemic convulsions.

Ferring

(POM)